Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-LONG: rFIXFc in Severe Hemophilia B
NCT01027364Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2009
- Primary completion
- Jul 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 17
01
Overview
A Phase 3 trial of eftrenonacog alfa in hemophilia B (HB), sponsored by Sanofi. Started Dec 2009; status: completed.
02
Drugs
eftrenonacog alfa
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT01027364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01027364.